LIXTE BIOTECHNOLOGY HOLDINGS, INC. - LIXT
Insiders (Form 4) · last 180 days · showing up to 200 transactions
· Form 144 is shown in the SEC filings tab
· Updating…
Visible: 0
Transaction codes:
P = Open-market purchase ·
S = Open-market sale ·
A = Grant/award ·
M = Exercise/conversion of derivative ·
G = Gift ·
F = Tax withholding ·
J = Other ·
A/D:
A = Acquired (buy/receive) ·
D = Disposed (sell/give)
| Filed | Owner | Title | Code | A/D | Shares | Price | Value | Shares after | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Jul 02, 2026 | Chief Financial Officer | A | A | 50,000.0 | 0.0 | 0.0 | 100,000.0 | View | |
| Jul 02, 2026 | — | A | A | 40,000.0 | 0.0 | 0.0 | 65,000.0 | View | |
| Jul 02, 2026 | CEO and Chairman of the Board | A | A | 350,000.0 | 0.0 | 0.0 | 700,000.0 | View | |
| Jul 02, 2026 | — | A | A | 15,000.0 | 0.0 | 0.0 | 40,000.0 | View | |
| Jul 02, 2026 | — | A | A | 15,000.0 | 0.0 | 0.0 | 40,000.0 | View | |
| Jul 02, 2026 | — | A | A | 30,000.0 | 0.0 | 0.0 | 55,000.0 | View | |
| Jun 01, 2026 | — | A | A | 25,000.0 | 0.0 | 0.0 | 25,000.0 | View | |
| Apr 17, 2026 | CEO and Chairman of the Board | D | D | 350,000.0 | — | — | 0.0 | View | |
| Apr 17, 2026 | CEO and Chairman of the Board | A | A | 350,000.0 | — | — | 350,000.0 | View | |
| Apr 17, 2026 | Chief Financial Officer | D | D | 50,000.0 | — | — | 0.0 | View | |
| Apr 17, 2026 | Chief Financial Officer | A | A | 50,000.0 | — | — | 50,000.0 | View | |
| Apr 17, 2026 | — | D | D | 25,000.0 | — | — | 0.0 | View | |
| Apr 17, 2026 | — | A | A | 25,000.0 | — | — | 25,000.0 | View | |
| Apr 17, 2026 | — | D | D | 25,000.0 | — | — | 0.0 | View | |
| Apr 17, 2026 | — | A | A | 25,000.0 | — | — | 25,000.0 | View | |
| Apr 17, 2026 | — | D | D | 25,000.0 | — | — | 0.0 | View | |
| Apr 17, 2026 | — | A | A | 25,000.0 | — | — | 25,000.0 | View | |
| Apr 17, 2026 | — | D | D | 25,000.0 | — | — | 0.0 | View | |
| Apr 17, 2026 | — | A | A | 25,000.0 | — | — | 25,000.0 | View |